it is under investigation in clinical trial NCT00572182 (it in Treating Young Patients With Recurrent or Refractory CNS Cancer). Notch Signaling Pathway Inhibitor it is a synthetic small molecule with potential antineoplastic activity. it inhibits the Notch signaling pathway, which may result in induction of growth arrest and apoptosis in tumor cells in which the Notch signaling pathway is overactivated. The Notch signaling pathway plays an important role in cell-fate determination, cell survival, and cell proliferation. 
